Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Dishman Pharma reports...

    Dishman Pharma reports fire at Bavla unit

    Written by supriya kashyap kashyap Published On 2017-03-09T11:19:17+05:30  |  Updated On 9 March 2017 11:19 AM IST
    Dishman Pharma reports fire at Bavla unit

    New Delhi : Drug firm Dishman Pharmaceuticals and Chemicals Ltd said there was fire at one of the units of its Bavla facility evening.


    "There was a fire incident at one of the units (Unit No.7) at our Bavla facility yesterday late evening and it had been brought under control. Health and safety of the people is always our prime concern and that has been achieved," Dishman Pharmaceuticals and Chemicals said in a BSE filing.


    It further said: "We also do not see any major financial impact due to the incident. Moreover, the company has an insurance policy for the assets damage and the loss of profit."


    Dishman Pharmaceuticals' Bavla plant near Ahmedabad is mainly used for making pharmaceutical intermediate and active pharmaceutical ingredients (APIs).


    The company maintained that there will be no impact on the production in any of the other units located at the Bavla facility.


    Dishman Pharmaceuticals and Chemicals was trading 0.29 per cent lower at Rs 237.15 on BSE.

    Active Pharmaceutical IngredientAPIBavla unitDishmanhealth
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok